Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

P. Ive · SciRah

Researcher profile · Semantic Scholar

P. Ive

Share profile

P. Ive — researcher profile on SciRah

h-index: 29
Works: 63
Citations: 3,670

Most-cited papers

Timing of Antiretroviral Therapy for HIV-1 Infection and Tuberculosis
D. Havlir, M. Kendall, P. Ive, J. Kumwenda +26 more
2011New England Journal of Medicine569 citations Open access
Semantic Scholar
Maraviroc versus efavirenz, both in combination with zidovudine-lamivudine, for the treatment of antiretroviral-naive subjects with CCR5-tropic HIV-1 infection.
D. Cooper, Jayvant R. Heera, J. Goodrich, M. Tawadrous +17 more
2010Journal of Infectious Diseases279 citations
Semantic Scholar
Nurse management is not inferior to doctor management of antiretroviral patients: The CIPRA South Africa randomised trial
I. Sanne, C. Orrell, M. Fox, F. Conradie +14 more
2010The Lancet255 citations Open access
Semantic Scholar
Unnecessary Antiretroviral Treatment Switches and Accumulation of HIV Resistance Mutations; Two Arguments for Viral Load Monitoring in Africa
K. Sigaloff, R. Hamers, C. Wallis, C. Kityo +9 more
2011Journal of Acquired Immune Deficiency Syndromes222 citations Open access
Semantic Scholar
SOLO: 48-week efficacy and safety comparison of once-daily fosamprenavir /ritonavir versus twice-daily nelfinavir in naive HIV-1-infected patients
J. Gathe, P. Ive, R. Wood, D. Schürmann +5 more
2004AIDS (London)218 citations Open access
Semantic Scholar
Efficiency and safety of the combination of moxifloxacin, pretomanid (PA-824), and pyrazinamide during the first 8 weeks of antituberculosis treatment: a phase 2b, open-label, partly randomised trial in patients with drug-susceptible or drug-resistant pulmonary tuberculosis.
R. Dawson, A. Diacon, D. Everitt, C. V. van Niekerk +15 more
2015The Lancet197 citations Open access
Semantic Scholar
Effect of pretreatment HIV-1 drug resistance on immunological, virological, and drug-resistance outcomes of first-line antiretroviral treatment in sub-Saharan Africa: a multicentre cohort study.
R. Hamers, R. Schuurman, K. Sigaloff, C. Wallis +11 more
2012Lancet. Infectious Diseases (Print)195 citations
Semantic Scholar
Patterns of HIV-1 drug resistance after first-line antiretroviral therapy (ART) failure in 6 sub-Saharan African countries: implications for second-line ART strategies.
R. Hamers, K. Sigaloff, A. Wensing, C. Wallis +10 more
2012Clinical Infectious Diseases186 citations Open access
Semantic Scholar
Relationship between Renal Dysfunction, Nephrotoxicity and Death among HIV Adults on Tenofovir
A. Brennan, D. Evans, M. Maskew, S. Naicker +4 more
2011AIDS (London)103 citations Open access
Semantic Scholar
High Rates of Survival, Immune Reconstitution, and Virologic Suppression on Second-Line Antiretroviral Therapy in South Africa
M. Fox, P. Ive, L. Long, M. Maskew +1 more
2010Journal of Acquired Immune Deficiency Syndromes92 citations Open access
Semantic Scholar
Initiating Patients on ART at CD4 Counts above 200 is Associated with Improved Treatment Outcomes in South Africa
M. Fox, I. Sanne, F. Conradie, Jennifer Zeinecker +7 more
2010AIDS (London)87 citations Open access
Semantic Scholar
Tuberculosis Immune Reconstitution Inflammatory Syndrome in A5221 STRIDE: Timing, Severity and Implications for HIV-TB programs
A. Luetkemeyer, M. Kendall, M. Nyirenda, Xingye Wu +7 more
2014Journal of Acquired Immune Deficiency Syndromes80 citations Open access
Semantic Scholar
Repeated Cycles of Recombinant Human Interleukin 7 in HIV-Infected Patients With Low CD4 T-Cell Reconstitution on Antiretroviral Therapy: Results of 2 Phase II Multicenter Studies.
R. Thiébaut, A. Jarne, J. Routy, I. Sereti +13 more
2016Clinical Infectious Diseases77 citations Open access
Semantic Scholar
Second-line antiretroviral treatment successfully resuppresses drug-resistant HIV-1 after first-line failure: prospective cohort in Sub-Saharan Africa.
K. Sigaloff, R. Hamers, C. Wallis, C. Kityo +9 more
2012Journal of Infectious Diseases77 citations
Semantic Scholar
Relationship between weight, efavirenz exposure, and virologic suppression in HIV-infected patients on rifampin-based tuberculosis treatment in the AIDS Clinical Trials Group A5221 STRIDE Study.
A. Luetkemeyer, S. Rosenkranz, Darlene Lu, Florence Marzan +8 more
2013Clinical Infectious Diseases69 citations Open access
Semantic Scholar
Intensive adherence counselling for HIV‐infected individuals failing second‐line antiretroviral therapy in Johannesburg, South Africa
M. Fox, Rebecca H. Berhanu, K. Steegen, C. Firnhaber +8 more
2016Tropical medicine & international health66 citations
Semantic Scholar
Clinically relevant thresholds for ultrasensitive HIV drug resistance testing: a multi-country nested case-control study.
S. Inzaule, R. Hamers, M. Noguera-Julián, Maria Casadellà +45 more
2018The Lancet HIV65 citations
Semantic Scholar
Suboptimal immune recovery during antiretroviral therapy with sustained HIV suppression in sub-Saharan Africa
Stefanie Kroeze, P. Ondoa, Cissy M. Kityo, M. Siwale +13 more
2018AIDS (London)60 citations Open access
Semantic Scholar
HIV–HBV Coinfection in Southern Africa and the Effect of Lamivudine- Versus Tenofovir-Containing cART on HBV Outcomes
R. Hamers, H. Zaaijer, C. Wallis, M. Siwale +6 more
2013Journal of Acquired Immune Deficiency Syndromes60 citations Open access
Semantic Scholar
Natural Killer cell activation distinguishes M. tuberculosis-mediated Immune reconstitution syndrome (IRIS) from chronic HIV and HIV-MTB co-infection
F. Conradie, A. Foulkes, P. Ive, Xiang-Fan Yin +7 more
2011Journal of Acquired Immune Deficiency Syndromes53 citations Open access
Semantic Scholar
Southern African HIV Clinicians Society guideline for the prevention, diagnosis and management of cryptococcal disease among HIV-infected persons: 2019 update
N. Govender, G. Meintjes, P. Mangena, J. Nel +25 more
2019Southern African Journal of HIV Medicine50 citations Open access
Semantic Scholar
Effect of pulmonary tuberculosis on mortality in patients receiving highly active antiretroviral therapy
D. Westreich, P. Macphail, A. Van Rie, Babatyi I Malope-Kgokong +5 more
2009AIDS (London)45 citations Open access
Semantic Scholar
Identification of a 251 Gene Expression Signature That Can Accurately Detect M. tuberculosis in Patients with and without HIV Co-Infection
N. Dawany, L. Showe, A. Kossenkov, Celia Chang +6 more
2014PLoS ONE42 citations Open access
Semantic Scholar
Efavirenz and rifampicin in the South African context: is there a need to dose increase efavirenz with concurrent rifampicin therapy?
C. Orrell, K. Cohen, F. Conradie, Jennifer Zeinecker +3 more
2011Antiviral Therapy40 citations Open access
Semantic Scholar
NeuroAIDS in Africa
Kevin Robertson, Jeffrey L. Liner, J. Hakim, J. Sankalé +28 more
2010Journal of Neurovirology40 citations Open access
Semantic Scholar
Efficacy and safety of maraviroc vs. efavirenz in treatment-naive patients with HIV-1: 5-year findings
D. Cooper, Jayvant R. Heera, P. Ive, M. Botes +8 more
2014AIDS (London)36 citations Open access
Semantic Scholar
Marginal Structural Models to Assess Delays in Second-Line HIV Treatment Initiation in South Africa
J. Rohr, P. Ive, C. Horsburgh, Rebecca H. Berhanu +7 more
2016PLoS ONE35 citations Open access
Semantic Scholar
Low rates of nucleoside reverse transcriptase inhibitor (NRTI) resistance detected in a well monitored cohort in South Africa accessing antiretroviral therapy
C. Wallis, Maria A Papathanasopolous, M. Fox, F. Conradie +7 more
2011Antiviral Therapy35 citations Open access
Semantic Scholar
Does Disseminated Nontuberculous Mycobacterial Disease Cause False-Positive Determine TB-LAM Lateral Flow Assay Results? A Retrospective Review
J. Nel, C. Lippincott, Rebecca H. Berhanu, D. Spencer +2 more
2017Clinical Infectious Diseases32 citations
Semantic Scholar
Tuberculosis Therapy Modifies the Cytokine Profile, Maturation State, and Expression of Inhibitory Molecules on Mycobacterium tuberculosis-Specific CD4+ T-Cells
K. Saharia, C. Petrovas, S. Ferrando-Martínez, M. Leal +5 more
2016PLoS ONE27 citations Open access
Semantic Scholar
Early warning indicators for population-based monitoring of HIV drug resistance in 6 African countries.
K. Sigaloff, R. Hamers, J. Menke, M. Labib +11 more
2012Clinical Infectious Diseases26 citations Open access
Semantic Scholar
Clinical and genetic determinants of plasma nevirapine exposure following an intrapartum dose to prevent mother-to-child HIV transmission.
S. Vardhanabhuti, E. Acosta, H. Ribaudo, P. Sévère +12 more
2013Journal of Infectious Diseases23 citations Open access
Semantic Scholar
Predictors of switch to and early outcomes on third-line antiretroviral therapy at a large public-sector clinic in Johannesburg, South Africa
D. Evans, K. Hirasen, Rebecca H. Berhanu, G. Malete +5 more
2018AIDS Research and Therapy21 citations Open access
Semantic Scholar
Increases in regimen durability associated with the introduction of tenofovir at a large public-sector clinic in Johannesburg, South Africa
A. Brennan, M. Maskew, P. Ive, Kate Shearer +3 more
2013Journal of the International AIDS Society21 citations Open access
Semantic Scholar
The relative contributions of HIV drug resistance, nonadherence and low-level viremia to viremic episodes on antiretroviral therapy in sub-Saharan Africa.
S. Inzaule, S. Bertagnolio, C. Kityo, M. Siwale +11 more
2020AIDS (London)19 citations Open access
Semantic Scholar
Outcomes of treatment of drug-susceptible tuberculosis at public sector primary healthcare clinics in Johannesburg, South Africa: A retrospective cohort study.
Eric P. Budgell, D. Evans, K. Schnippel, P. Ive +2 more
2016South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde19 citations Open access
Semantic Scholar
Long-term HIV treatment outcomes and associated factors in sub-Saharan Africa: multicountry longitudinal cohort analysis
S. Inzaule, Stefanie Kroeze, C. Kityo, M. Siwale +13 more
2022AIDS (London)18 citations Open access
Semantic Scholar
Developing a predictive risk model for first-line antiretroviral therapy failure in South Africa
J. Rohr, P. Ive, C. Horsburgh, Rebecca H. Berhanu +7 more
2016Journal of the International AIDS Society18 citations Open access
Semantic Scholar
Low Prevalence of Liver Disease but Regional Differences in HBV Treatment Characteristics Mark HIV/HBV Co-Infection in a South African HIV Clinical Trial
P. Ive, W. MacLeod, N. Mkumla, C. Orrell +6 more
2013PLoS ONE17 citations Open access
Semantic Scholar
Predictors and outcomes of Mycobacterium tuberculosis bacteremia among patients with HIV and tuberculosis co-infection enrolled in the ACTG A5221 STRIDE study
J. Crump, Xingye Wu, M. Kendall, P. Ive +4 more
2015BMC Infectious Diseases16 citations Open access
Semantic Scholar
The early effects of stavudine compared with tenofovir on adipocyte gene expression, mitochondrial DNA copy number and metabolic parameters in South African HIV‐infected patients: a randomized trial
C. N. Menezes, R. Duarte, C. Dickens, T. Dix-Peek +9 more
2013HIV Medicine13 citations Open access
Semantic Scholar
The management and outcomes of Staphylococcus aureus bacteraemia at a South African referral hospital: A prospective observational study.
Nicola Steinhaus, M. Al-Talib, P. Ive, T. Boyles +4 more
2018International Journal of Infectious Diseases11 citations Open access
Semantic Scholar
Previous antiretroviral drug use compromises standard first-line HIV therapy and is mediated through drug-resistance
S. Inzaule, Cissy M. Kityo, M. Siwale, A. Akanmu +11 more
2018Scientific Reports11 citations Open access
Semantic Scholar
Nurse management is not inferior to doctor management of antiretroviral patients: The CIPRA South Africa randomised trial
I. Sanne, C. Orrell, M. Fox, F. Conradie +15 more
20118 citations
Semantic Scholar
Safety and Pharmacokinetics of Double-Dose Lopinavir/Ritonavir + Rifampin vs. Lopinavir/Ritonavir + Daily Rifabutin for Treatment of HIV-TB Coinfection.
M. Kendall, U. Lalloo, C. Fletcher, Xingye Wu +4 more
2021Clinical Infectious Diseases7 citations Open access
Semantic Scholar
The Feasibility of Using Screening Criteria to Reduce Clinic Visits for Stable Patients on Antiretroviral Therapy in South Africa
W. Macleod, M. Maskew, Imogen Jaffray, A. P. Macphail +2 more
2013Journal of Acquired Immune Deficiency Syndromes5 citations Open access
Semantic Scholar
failure: prospective cohort in sub-Saharan Africa
K. Sigaloff, R. Hamers, C. Wallis, C. Kityo +7 more
20125 citations
Semantic Scholar
Hepatitis B and HIV co-infection in South Africa: just treat it!
C. Firnhaber, P. Ive
2009Southern African Journal of HIV Medicine5 citations Open access
Semantic Scholar
Decreased sexual risk behaviour after the diagnosis of HIV and initiation of antiretroviral treatment - a study of patients in Johannesburg
J. Fougelberg, S. Karlstrom, Y. Veriava, P. Ive +1 more
20065 citations
Semantic Scholar
Reduced CCR5 Expression and Immune Quiescence in Black South African HIV-1 Controllers
Anabela C. P. Picton, M. Paximadis, G. W. Koor, Avani Bharuthram +4 more
2021Frontiers in Immunology4 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

I. Sanne×19
Invite
I. Sanne — researcher profile on SciRah
W. Stevens×18
Invite
W. Stevens — researcher profile on SciRah
K. Sigaloff×12
Invite
K. Sigaloff — researcher profile on SciRah
R. Hamers×12
Invite
R. Hamers — researcher profile on SciRah

×10

Invite

M. Siwale — researcher profile on SciRah

K. Mandaliya×10

Invite

K. Mandaliya — researcher profile on SciRah

M. Wellington×10

Invite

M. Wellington — researcher profile on SciRah

Invite

C. Wallis — researcher profile on SciRah

Invite

C. Kityo — researcher profile on SciRah

Invite

M. Botes — researcher profile on SciRah

Invite

M. Fox — researcher profile on SciRah

Tobias F. Rinke de Wit×8

Invite

Tobias F. Rinke de Wit — researcher profile on SciRah